Bright Minds Biosciences Inc.
NASDAQ:DRUGBiotechnology
Healthcare
$20.76 +1.04%
+$0.62 today
- Market cap
- $204.78M
- Beta
- -0.11
- P/E (TTM)
- -29.8
- EPS (TTM)
- -$2.87
52W Low $23.18High $123.75
Volume 0.14M
Average 0.27M
DRUG Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
No reported Net Margin figures are available to summarize.
Net Margin history
Percent of revenue · from the income statement
No Net Margin data reported for this period type.
Net Margin vs competitors
How DRUG compares with its peers on the latest reported figures
No competitor Net Margin figures are available to compare.
Income Statement
CAD
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 6.31M | 12.18M | 5M | 1.18M | 11.08M |
| Selling, General & Admin | 2.31M | 2.55M | 2.2M | 1.45M | 2.57M |
| Operating Expenses | 8.62M | 14.98M | 7.39M | 2.82M | 13.94M |
| Depreciation & Amortization | 8.62M | 6.04K | 72.45K | 73.36K | 76.87K |
| EBITDA | (27.64K) | (14.96M) | (7.3M) | (2.73M) | (12.15M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (8.62M) | (14.98M) | (7.39M) | (2.82M) | (13.94M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 0 | 0 | 0 | 30.13K | 1.52M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (27.64K) | 10.15K | 14.19K | 20.82K | 1.71M |
| Income Before Tax | (8.65M) | (14.96M) | (7.37M) | (2.8M) | (12.23M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (8.65M) | (14.96M) | (7.37M) | (2.8M) | (12.23M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (4.74) | (6.15) | (1.98) | (0.65) | (1.78) |
| EPS (Diluted) | (4.74) | (6.15) | (1.98) | (0.65) | (1.78) |
| Weighted Avg Shares | 1.79M | 2.47M | 3.72M | 4.31M | 6.88M |
| Weighted Avg Shares (Diluted) | 1.79M | 2.47M | 3.72M | 4.31M | 6.88M |
Bright Minds Biosciences Inc.
NASDAQ:DRUG
Intrinsic Alpha fair value
Locked
Current Price
$20.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.